NCT02212782View on ClinicalTrials.gov

the Pharmacokinetic Profiles of Linagliptin With DW1029M

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

January 31, 2015

Conditions
Healthy
Interventions
DRUG

Linagliptin 5mg

Linagliptin 5mg once daily for 7 days

DRUG

DW1029M 1200mg and Linagliptin 5mg

Linagliptin 5mg 1 tablet once daily and DW1029M 300mg 2 tablets b.i.d for 7 days

Trial Locations (1)

561-712

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Dong Wha Pharmaceutical Co. Ltd.

INDUSTRY